CORRECTION article

Front. Pharmacol., 17 January 2024

Sec. Pharmacology of Anti-Cancer Drugs

Volume 15 - 2024 | https://doi.org/10.3389/fphar.2024.1343756

Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

  • 1. Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Chennai, Tamil Nadu, India

  • 2. Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia

  • 3. Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia

  • 4. Department of Foundation, RCSI and UCD Malaysia Campus, George Town, Malaysia

  • 5. Department of Periodontics and Community Dental Sciences, College of Dentistry, King Khalid University, Abha, Saudi Arabia

  • 6. Faculty of Health and Life Sciences, INTI International University, Nilai, Malaysia

  • 7. School of Pharmacy, Monash University Malaysia, Subang Jaya, Selangor, Malaysia

  • 8. Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India

  • 9. Trichy Research Institute of Biotechnology Pvt Ltd., Trichy, Tamil Nadu, India

  • 10. Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Selangor, Malaysia

  • 11. Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh, Perak, Malaysia

  • 12. Department of Biological Sciences and Centre for Virus and Vaccine Research, School of Medical and Life Sciences, Sunway University, Subang Jaya, Selangor, Malaysia

  • 13. Department of Pharmacology, Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU), Chennai, Tamil Nadu, India

In the published article, there was an error in the Article Title. Instead of “Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy,” it should be “Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy.”

Additionally, there was an error in the Conflict of Interest statement. The original statement omitted the declaration for commercial affiliations. The correct Conflict of Interest statement appears below.

Statements

Conflict of interest

Author AE was employed by Trichy Research Institute of Biotechnology Pvt Ltd.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

benzylisoquinoline alkaloids, stylopine, MG-63, osteosarcoma, VEGFR2

Citation

Velayutham NK, Thamaraikani T, Wahab S, Khalid M, Ramachawolran G, Abullais SS, Wong LS, Sekar M, Gan SH, Ebenezer AJ, Ravikumar M, Subramaniyan V, Izzati Mat Rani NN, Wu YS and Jeyabalan S (2024) Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Front. Pharmacol. 15:1343756. doi: 10.3389/fphar.2024.1343756

Received

24 November 2023

Accepted

08 January 2024

Published

17 January 2024

Volume

15 - 2024

Edited and reviewed by

Shoib Sarwar Siddiqui, University of Hertfordshire, United Kingdom

Updates

Copyright

*Correspondence: Tamilanban Thamaraikani, ; Gobinath Ramachawolran, ; Mahendran Sekar, ; Ling Shing Wong,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics